Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Taking the next step-Advancing bladder cancer management.
Vlahou A, Black PC, Goebell PJ, Kamat AM, Nawroth R, Schmitz-Dräger BJ. Vlahou A, et al. Among authors: nawroth r. Urol Oncol. 2016 Oct;34(10):435-6. doi: 10.1016/j.urolonc.2016.03.004. Urol Oncol. 2016. PMID: 27658683 No abstract available.
Wntless promotes bladder cancer growth and acts synergistically as a molecular target in combination with cisplatin.
Schmid SC, Sathe A, Guerth F, Seitz AK, Heck MM, Maurer T, Schwarzenböck SM, Krause BJ, Schulz WA, Stoehr R, Gschwend JE, Retz M; German Bladder Cancer Network; Nawroth R. Schmid SC, et al. Among authors: nawroth r. Urol Oncol. 2017 Sep;35(9):544.e1-544.e10. doi: 10.1016/j.urolonc.2017.04.015. Epub 2017 May 10. Urol Oncol. 2017. PMID: 28501564
New horizons in bladder cancer research.
Boormans JL, Zwarthoff EC, Black PC, Goebell PJ, Kamat AM, Nawroth R, Seiler R, Williams SB, Schmitz-Dräger BJ. Boormans JL, et al. Among authors: nawroth r. Urol Oncol. 2020 Dec;38(12):867-885. doi: 10.1016/j.urolonc.2018.12.014. Epub 2019 Mar 7. Urol Oncol. 2020. PMID: 30852032 Review.
98 results